Improving Shingrix Vaccination Among US Veterans Receiving Immunosuppression

NAEnrolling by invitationINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

September 16, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

June 30, 2026

Conditions
Immunosuppresion
Interventions
OTHER

Access to Shingrix dashboard

The investigators will build and grant access to a clinical dashboard that exists behind the VA firewall. The dashboard will identify Veterans from each VA facility who are receiving immunosuppressants (prescribed via the VA). The dashboard will also provide information about the number of Shingrix vaccines each patient has received (which have been documented within the VA electronic health record). VA clinicians will have access to view information about patients based on their VA electronic health record permissions.

Trial Locations (1)

94121

San Francisco VA, San Francisco

All Listed Sponsors
collaborator

San Francisco Veterans Affairs Medical Center

FED

lead

University of California, San Francisco

OTHER

NCT06596148 - Improving Shingrix Vaccination Among US Veterans Receiving Immunosuppression | Biotech Hunter | Biotech Hunter